Charles N Landen Selected Research

Charles N Landen Research Topics

Disease

64	Neoplasms (Cancer) 01/2023 - 05/2003
58	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 12/2004
18	Carcinoma (Carcinomatosis) 05/2019 - 02/2006
10	Ovarian Epithelial Carcinoma 11/2017 - 02/2006
4	Neoplasm Metastasis (Metastasis) 01/2022 - 03/2006
4	Ascites 01/2019 - 03/2006
3	Genomic Instability 01/2023 - 12/2004
3	Carcinogenesis 01/2016 - 08/2004
2	Necrosis 10/2007 - 10/2006
1	Bites and Stings (Sting) 10/2021
1	Hypoxia (Hypoxemia) 01/2019

Drug/Important Bio-Agent (IBA)

12	Small Interfering RNA (siRNA)IBA 05/2019 - 08/2005
12	Docetaxel (Taxotere)FDA Link 11/2011 - 12/2005
11	Paclitaxel (Taxol)FDA LinkGeneric 11/2019 - 08/2005
11	PlatinumIBA 01/2019 - 08/2006
11	taxaneIBA 08/2014 - 12/2005
8	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010 - 08/2006
7	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 02/2012
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2006
7	1,2-oleoylphosphatidylcholine (DOPC)IBA 05/2014 - 08/2005
6	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2008
6	Monoclonal AntibodiesIBA 01/2021 - 10/2006
6	Liposomes (Liposome)IBA 05/2019 - 08/2005
6	Proliferating Cell Nuclear Antigen (PCNA)IBA 11/2011 - 09/2006
5	Bevacizumab (Avastin)FDA Link 01/2023 - 12/2007
5	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2006
4	DNA (Deoxyribonucleic Acid)IBA 10/2021 - 10/2006
3	Focal Adhesion Protein-Tyrosine KinasesIBA 05/2019 - 12/2005
3	Niclosamide FDA Link 10/2018 - 07/2014
3	CateninsIBA 10/2018 - 07/2014
3	Cell-Free Nucleic AcidsIBA 01/2018 - 10/2006
3	AEE 788 (AEE788)IBA 07/2007 - 10/2006
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2006 - 08/2004
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2006
2	AntibodiesIBA 11/2021 - 01/2018
2	CX 5461IBA 10/2021 - 11/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2021 - 02/2018
2	JMS-053IBA 01/2021 - 02/2018
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2016
2	Oncogene Proteins (Oncogene Protein)IBA 02/2018 - 11/2006
2	Death Domain ReceptorsIBA 01/2018 - 03/2012
2	Proteasome InhibitorsIBA 08/2014 - 01/2008
2	sonidegibIBA 08/2014 - 07/2012
2	Bortezomib (Velcade)FDA Link 08/2014 - 01/2008
2	Caspase 3 (Caspase-3)IBA 04/2013 - 12/2005
2	sulforaphaneIBA 03/2013 - 01/2013
2	TeaIBA 03/2013 - 01/2013
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 03/2013 - 01/2013
2	EndoglinIBA 01/2013 - 02/2012
2	CytokinesIBA 02/2012 - 03/2008
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 11/2011 - 11/2006
2	LigandsIBA 09/2011 - 04/2008
2	EnzymesIBA 12/2010 - 02/2006
2	etaracizumabIBA 12/2009 - 11/2008
2	Integrin alphaVbeta3IBA 12/2009 - 11/2008
2	Integrin beta3 (GPIIIa)IBA 12/2009 - 11/2008
2	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2007 - 08/2006
2	Adrenergic Receptors (Adrenergic Receptor)IBA 11/2007 - 08/2006
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2007 - 01/2006
2	Epinephrine (Adrenaline)FDA LinkGeneric 11/2007 - 01/2006
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 11/2007 - 01/2006
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 07/2007 - 01/2007
2	Matrix Metalloproteinase 14 (MT1-MMP)IBA 01/2007 - 03/2006
1	Immune Checkpoint InhibitorsIBA 01/2023
1	B7-H1 AntigenIBA 01/2023
1	atezolizumabIBA 01/2023
1	Drug CombinationsIBA 10/2021
1	InterferonsIBA 10/2021
1	Interferon Type IIBA 10/2021
1	PlectinIBA 01/2021
1	Arsenic Trioxide (Trisenox)FDA Link 11/2019
1	Arsenicals (Arsenic Compounds)IBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	SphingosineIBA 11/2018
1	Selective Estrogen Receptor Modulators (SERM)IBA 11/2018
1	CeramidesIBA 11/2018
1	LipidsIBA 11/2018
1	Fingolimod Hydrochloride (FTY720)FDA Link 11/2018
1	Tamoxifen FDA LinkGeneric 11/2018
1	Protein Tyrosine PhosphatasesIBA 02/2018
1	RNA Polymerase I (Polymerase I, RNA)IBA 11/2017
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 10/2017
1	salicylamideIBA 12/2016
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2016
1	Sialic AcidsIBA 01/2016
1	GlycosyltransferasesIBA 01/2016
1	Glycoproteins (Glycoprotein)IBA 01/2016
1	Gemcitabine FDA Link 01/2016
1	RNA (Ribonucleic Acid)IBA 09/2014
1	UbiquitinIBA 08/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2014
1	Gamma Secretase Inhibitors and ModulatorsIBA 08/2014
1	veliparibIBA 08/2014

Therapy/Procedure

32	Therapeutics 01/2022 - 08/2005
18	Drug Therapy (Chemotherapy) 01/2023 - 10/2006
3	Immunotherapy 01/2023 - 01/2014
3	Aftercare (After-Treatment) 01/2022 - 12/2005
1	Salpingo-oophorectomy 01/2020
1	Neoadjuvant Therapy 01/2018
1	Menstrual Hygiene Products (Menstrual Pad) 11/2014